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Abstract 
Background: Non-adherence to prescribed medication and health regimen has been identified as responsible for 
poor health outcomes. This study investigates the reasons for medication non-adherence in outpatient setting 
among malaria patients in Nigeria.  
Methods: This research adopted quantitative research methods. A well-structured questionnaire was completed 
by 440 respondents with minimum age of 18 years. The aim of the questionnaire was to get respondents’ reasons 
for non-adherence to medication. The demographic details of the respondents were also captured. 
Results: Age, gender, educational level, marital status and medication payment were found not to influence 
non-adherence while employment was a significant variable. Respondents also indicated fear of death, 
nauseating smell of drugs, religious beliefs, the side effects of medication, the fear of taking counterfeit drugs or 
drugs that are past their expiry dates as also responsible for non-adherence. 
Conclusion: The results highlighted reasons for poor adherence in southwest Nigeria. Interventions can be 
targeted towards these reasons. 
Keywords: outpatient, non-adherence, interventions, healthcare, Nigeria 
1. Introduction 
Health challenges present arguably the most significant barrier to sustainable global development. Disease and 
the lack of adequate preventative care take a significant toll on both developing populations and economies. 
According to the United Nations Report (2008) and the World Health Statistics (2010), the health related 
Millennium Development Goals (MDGs) include: reducing child mortality, improving maternal health and 
combating Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome (HIV/AIDS), Malaria, 
Tuberculosis and other diseases. In 2008, there were an estimated 243 million cases of malaria causing 863,000 
deaths; mostly of children under five (5) years old (World Malaria Report, 2009). Access to treatment (especially 
artemisinin-based combination therapy) was inadequate in all countries surveyed in 2007 and 2008. By the end 
of 2012, the UN reported broad and significant progress in the achievement of the MDGs across countries and 
regions (United Nations, 2012). There was an increase in access to treatment for people living with HIV across 
the different regions; tuberculosis incidence rates were reduced while global malaria deaths have also declined. 
The estimated incidence of malaria decreased globally by seventeen per cent (17%) since year 2000. Over the 
same period, malaria-specific mortality rates have decreased by twenty-five per cent (25%). Reported malaria 
cases fell by more than fifty per cent (50%) between 2000 and 2010 in 43 of the 99 countries with ongoing 
malaria transmission. Despite the great progress recorded with the MDGs across regions, the targets have not 
been reached. 
The most common contributors to the disease burden in Nigeria are Malaria, Tuberculosis (TB) and HIV/AIDS 
(Labiran et al., 2008). These diseases are chronic, infectious/non-infectious, and highly prevalent. The current 
goals and objectives of the health sector include: reduction of the disease burden from HIV/AIDS and control 
and eradication of malaria and tuberculosis. Adherence to long-term therapy in outpatient setting is required to 
reduce prevalence of these diseases (WHO, 2003). Adherence is generally described as the extent to which 
patients take medications as prescribed by their health care providers (Osterberg & Blaschke, 2005). Rates of 
adherence for individual patients are usually reported as the percentage of the prescribed doses of the medication 
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actually taken by the patient over a specified period. Some investigators have further refined the definition of 
adherence to include data on dose taking (taking the prescribed number of pills each day) and the timing of doses 
(taking pills within a prescribed period) (Osterberg & Blaschke, 2005).  
Non-adherence to prescribed medication and health regimen has been identified as responsible for poor health 
outcomes. Most researchers agree that at least 50% of patients fail to receive the full benefit of prescribed drugs 
due to inadequate adherence (Rogers & Bullman, 1995). Non-adherence and poor adherence to long-term 
therapies severely compromise the effectiveness of treatment, making this a critical issue in population health 
both from the perspective of quality of life and of health economics. There are studies that have attempted to 
identify the predictors of adherence and non-adherence. These variables are behavioral and dynamic; and have 
been classified as provider behaviors, health system factors and patient attributes. In (Brown, 1994; Wright, 1998; 
Scopp, 2000), provider behaviors were discussed and identified. These research works identified that factors 
affecting interaction and communication between healthcare providers and patients were the key determinants of 
adherence. Health system variables include availability and accessibility of services, support for education of 
patients, data collection and information management, provision of feedback to patients and healthcare providers, 
and training provided to health service providers (WHO, 2003).  
Age, sex, income, marital status, ethnic background, and race are patient characteristics but have not been found 
to be direct determinants of adherence (Haynes et al., 1980; Kaplan & Simon, 1990). However, a strong 
relationship exists between medication adherence and perceptions of disease factors and beliefs about treatment. 
According to Freitas et al. (2010), the predictors of adherence are classified into three categories: (a) 
demographic, social and economic factors; (b) factors related to the disease and the therapeutic regimen 
prescribed; and (c) factors related to the patient’s relationship with health professionals and services.  
Adherence to malaria treatment, that is taking all the doses that are given, is very important for successful 
malaria treatment outcome. Non-adherence to malaria treatment can lead to re-oocurence of the ailment, the 
parasites becoming resistant to the drug, so in future the drug will be less effective against the parasites. Critical 
to patients’ adherence is good communication between healthcare providers and their patients 
(http://labspace.open.ac.uk). Adherence to malaria medication in patients has been linked to knowledge of 
malaria, access to information on medication for malaria, perceived benefit from the medication, and perceived 
barriers to treatment. In Brazil, the low compliance with malaria treatment probably explains the large number of 
Plasmodium vivax malaria relapses observed in the past years. Pereira et al. (2011) studied the proportion of 
patients adhering to the Plasmodium vivax malaria treatment with chloroquine and primaquine in the dosages 
recommended by the Brazilian Ministry of Health. Patients who were being treated for Plasmodium vivax 
malaria with chloroquine plus primaquine were eligible for the study. On the seventh day of taking primaquine, 
they were visited at their home and were interviewed. The patients were classified as probably adherent, if they 
reported having taken all the medication as prescribed, in the correct period of time and dosage, and had no 
medication tablets remaining; probably non-adherent, if they reported not having taken the medication, in the 
correct period of time and dosage, and did not show any remaining tablets; and certainly non-adherent, if they 
showed any remaining medication tablets. The study showed that 242 of the 280 patients reported having 
correctly followed the prescribed instructions and represented a treatment adherence frequency (CI95%) of 
86.4% (81.7%-90.1%).  
Diala et al. (2013) conducted a cross-sectional study in peri-urban and rural communities of Nasarrawa and 
Cross-River states in Nigeria to understand the perceptions of intermittent preventive treatment of malaria in 
pregnancy (IPTp) and barriers to adherence. Study instruments were based on the socio-ecological model and its 
multiple levels of influences, taking into account individual, community, societal, and environmental contexts of 
behaviour and social change. The study found that systems-based challenges (stockouts, lack of provider 
knowledge of IPTp protocols) coupled with individual women’s beliefs and lack of understanding of IPT 
contribute to low uptake and adherence. Many pregnant women are reluctant to seek care for an illness they do 
not have. Those with malaria often prefer to self-medicate through drug shops or herbs, though those who seek 
clinic-based treatment trust their provider and willingly accept medicine prescribed. 
The aim of this paper is to identify and evaluate some of the reasons for medication non-adherence among 
malaria patients in outpatient setting in major cities of southwest Nigeria. 
2. Method 
This research is the first phase of a cross-sectional survey on medication adherence. The study was carried out in 
some major cities in southwest Nigeria. We investigated socio-demographic characteristics and reasons that have 
been identified from literature (Nemes et al., 2004; Vik et al., 2004; Jackson et al., 2005; Vlasnik et al., 2005; 
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Erah & Arute, 2008; Olowookere et al., 2008; Adisa et al., 2009; Uzochukwu et al., 2009; Ekwunife et al., 2010; 
and Farley et al., 2010) and listed in Tables 1 and 2 for possible correlation with medication adherence. This 
research adopted quantitative research methods. The survey instrument combined the instruments used in 
previous research studies on medication adherence and found in (Erah & Arute, 2008; Uzochukwu et al., 2009; 
Ekwunife et al., 2010). Provision was made for respondents to indicate other reasons not captured by the 
identified reasons. The questionnaire also captured socio-demographic details such as sex, age range, and level 
of education, employment status, occupation and health plan of respondents. Copies of the instrument were 
administered to a convenient and random sample.  
The administration of the survey followed an approach which was meant to ensure the validity of the responses 
to questions on medication adherence behavior. All study participants were informed of their rights by means of 
an informed consent letter that briefly stated the purpose of the study, its significance, issues of confidentiality, 
and rights of the respondent. Each participant was also informed before the interview took place that she/he was 
under no obligation to participate. The informed consent was read aloud to the hearing of prospective 
participants. Furthermore, participants were informed of their right of confidentiality and that at no time should 
they disclose any information with which they felt uncomfortable. To maintain confidentiality, there was no 
identifying information on any questionnaire. The data collected were entered into Statistical Package for Social 
Sciences (SPSS) version 16.0 software for analysis. The Chi-square test, linear regression and independent t-test 
were used for evaluating factors associated with medication adherence. 
2.1 Research Design 
A cross sectional survey was used for this study. The study was designed to gather information about the study 
population at a particular point in time. Data were collected by adopting quantitative methods using a 
paper-based questionnaire and conducting semi-structured interviews. Before distributing the questionnaire and 
conducting the interviews, all study participants were informed of their rights, benefits and risks by means of an 
informed consent letter that briefly stated the purpose of the study, its significance, issues of confidentiality, and 
rights of the respondent. Each participant was also informed before the interview took place that she/he was 
under no obligation to participate. The informed consent was read aloud to the hearing of prospective 
participants. Furthermore, participants were informed of their right of confidentiality and that at no time should 
they disclose any information with which they felt uncomfortable. To maintain confidentiality, there was no 
identifying information on any questionnaire. The survey items were also translated to the native language 
“Yoruba dialect” for the benefit of those who could not read in English. The respondents returned their 
completed questionnaire to the researcher and research assistants immediately. The study population was adult 
Nigerians who were on any form of malaria medication in outpatient settings. Our intention is to understand the 
adherence behaviour of individuals on medications in outpatient setting and design an intervention based on the 
findings, hence, the study included individuals who were on any form of malaria medication. The inclusion 
criteria for participants in the study were 1) 18 years of age or older; 2) must be required to take some form of 
medication for the treatment of malaria; 3) the medication must be over a period of time e.g two days; 4) the 
medication must be taken in an outpatient setting, the individual must not be on admission in the hospital. The 
study sample was a combination of random and convenience sample selected from some major cities – Abeokuta, 
Ado, Akure, Ibadan, Lagos and Oshogbo - in the southwest region of Nigeria based on the above criteria. The 
sample size was calculated based on the following assumption: since we were using a random sample, our 
intention was to maximize responses from as many subjects as possible. Hence, confidence level was set at 95%, 
precision level (margin of error) is also given as +/- 5%; we projected a 90% response rate, 0.9, and calculated 
our sample to be 427 respondents. This sample size is to estimate the proportion of adherent to non-adherent 
respondents.  
3. Results 
3.1 Statistics and Data Analysis 
Six hundred (600) questionnaires were distributed; four hundred and sixty (460) returned questionnaires were 
received. Ten (10) questionnaires were dropped as a result of incomplete responses for each of the measurement 
items. Ten (10) questionnaires were dropped because the respondents gave invalid response of “not taking any 
form of medication”. This left four hundred and forty (440) questionnaires for the statistical analysis, which 
represented a 73% valid return rate, this is statistically significant. This was calculated via a ratio of the returned 
and valid questionnaires and the administered questionnaires. 
The sample is made up of two hundred and one (201) males and two hundred and five (205) females while 
thirty-four respondents did not indicate their gender. One hundred and fifty six (156) respondents are between 
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28-37 years (35.5%), accounting for a major part of the entire population, one hundred and forty four (144) 
respondents are between 18-27 years (32.7%), ninety three (93) are between 38-47 years (21.1%), seventeen (17) 
fall into 48-57 age range (3.9% ), 0.9% (4) respondents are in the 58-67 age range while twenty six (26) 
respondents did not disclose their age range (5.9%). One hundred and ninety four (194) respondents are single; 
two hundred and twenty (220) are married, one (1) divorced and two (2) widowed while twenty three (23) 
respondents did not disclose their marital status. Also, a greater portion of the respondents pay for their 
medication themselves. The socio-demographic characteristics of the respondents are represented in Table 1. 
 
Table 1. Socio-demographic characteristics of respondents 
Variable Frequency Percent 
Age   
18-27 144 32.7 
28-37 156 35.5 
38-47 93 21.1 
48-57 17 3.9 
58-67 4 0.9 
Missing Value 26 5.9 
Total 440 100.0 
Marital Status   
Single 194 44.1 
Married 220 50.0 
Divorced 1 0.2 
Widowed 2 0.5 
Missing Value 23 5.2 
Total 440 100.0 
Gender   
Male 201 45.7 
Female 205 46.6 
Missing Value 34 7.7 
Total 440 100.0 
Employment Status   
Employed 293 66.6 
Self-employed 37 8.4 
Unemployed 80 18.2 
Missing value 30 6.8 
Total 440 100.0 
State/Location   
Lagos 88 20.0 
Ogun 117 26.6 
Ondo 79 18.0 
Osun 12 2.7 
Oyo 111 25.2 
Ekiti 3 0.7 
Others 15 3.4 
Missing value 15 3.4 
Total 440 100.0 
Educational Level   
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Primary school and below 4 0.9 
Secondary school 64 14.5 
Graduate 227 51.6 
Postgraduate 127 28.9 
Missing value 18 4.1 
Total 440 100.0 
Medical Bill Payment   
Self 261 59.3 
NHIS 56 12.7 
Family 82 18.6 
Welfare/Charity 2 0.5 
Employer 31 7.0 
Missing value 8 1.8 
Total 440 100.0 
 
Table 2 presents the reasons investigated and estimated as responsible for poor adherence to medication in 
respondents who have been or currently on prescribed malaria treatment.  
 
Table 2. Factors influencing medication adherence rate 
Label Question N (Yes) N (No) %(Yes) %(No) 
MAB1 I do not understand the need for medication 40 400 9.1 90.9 
MAB2 I do not believe the usefulness of medication 42 398 9.5 90.5 
MAB3 I do not get support and motivation 71 369 16.1 83.9 
MAB4 I do not want to make medications-taking a habit 281 159 63.9 36.1 
MAB5 Medication is not readily available 78 362 17.7 82.3 
MAB6 I do not have a good relationship with the doctor 56 384 12.7 87.3 
MAB7 I do not keep my medications in sight and within reach. 117 323 26.6 73.4 
MAB8 I am not satisfied with the treatment 81 359 18.4 81.6 
MAB9 I lack confidence in the doctor 48 392 10.9 89.1 
MAB10 My medication is expensive 76 364 17.3 82.7 
MAB11 I do not like the side effects of the medication 212 228 48.2 51.8 
MAB12 I do not want to mix medication with alcohol/any other 
substance 
172 268 39.1 60.9 
MAB13 I feel worse when I take my medications 54 386 12.3 87.7 
MAB14 The medication/treatment has no effect 53 387 12.0 88.0 
MAB15 I feel better before I finish the medication/treatment 292 148 66.4 33.6 
MAB16 The duration of the treatment is too long 119 321 27.0 73.0 
MAB17 I have to take too many medicines/drugs 88 352 20.0 80.0 
MAB18 I am lazy at taking medicines 159 281 36.1 63.9 
MAB19 I find it difficult to take my medicines according to prescription 
e.g during meals, every 8 hours, with a lot of liquid, etc 
156 284 35.5 64.5 
MAB20 I have no time, always busy 102 338 23.2 76.8 
MAB21 I have strong religious or cultural beliefs regarding health and 
medication 
90 350 20.5 79.5 
MAB22 I do not like taking medications 167 273 38.0 62.0 
MAB23 I forget 146 294 33.2 66.8 
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From the responses, 281 (63.9%) respondents do not follow their treatment plan because they do not want to 
make it a habit (MAB4), 117 (26.6%) respondents do not keep their medication in sight and within reach 
(MAB7), 212 (48.2%) respondents do not like the side effects of medications (MAB11), 172 (39.1%) 
respondents do not want to mix medication with alcohol or any other substance (MAB12), 292 (66.4%) 
respondents indicate they feel better before they finish the medication (they experience some level of wellness 
before completing the required dosage) (MAB15), 119 (27.0%) respondents feel the duration of the medication 
is too long (MAB16), 159 (36.1%) respondents are lazy at taking medications (medicines) (MAB18), 156 
(35.5%) respondents find it difficult to take medicines according to prescription (MAB19), 102 (23.2%) 
respondents indicate a busy schedule (MAB20), 167 (38.0%) respondents do not like taking medicines (MAB22), 
while 146 (33.2%) respondents forget to take their drugs (MAB23).  
Furthermore, 40 (9.1%) respondents say they do not understand the need for medication (MAB1), 42 (9.5%) 
respondents do not believe the usefulness of medication (MAB2), 71 (16.1%) respondents would follow their 
treatment plan if they get support and motivation (MAB3), 78 (17.7%) respondents indicated non-availability of 
medication (MAB5), 56 (12.7%) respondents do not have a good relationship with their doctors (MAB6), 81 
(18.4%) respondents are not satisfied with their treatment, hence do not take their medication (MAB8), 48 
(10.9%) respondents lack confidence in their doctor (MAB9), 76 (17.3%) respondents complained of high cost 
of medication, 54 (12.3%) respondents explained that they feel worse when they take medications (MAB13), 53 
(12.0%) respondents believe the medication has no effect, 88 (20.0%) respondents have to take too many 
drugs/medicines (MAB17), while 90 (20.5%) respondents have strong religious or cultural beliefs regarding 
health and medication (MAB21).  
In the bi-variate analysis carried out, the reason with the highest response rate (MAB15) represented by “I feel 
better before I finish the medication” (experiencing some level of wellness before completing the required 
dosage) was used to measure medication adherence. Respondents’ age, marital status, educational level, 
employment status, gender and medication payment were all positively correlated to medication adherence. A 
chi-square test was performed and no relationship was found between age and medication adherence [X2 (4, 
N=440) = 0.858, p= .931]; marital status and medication adherence [X2 (1, N=440) = 0.533, p= .465]; 
educational level and medication adherence [X2 (1, N=440) = 1.529, p= .216]; gender and medication adherence 
[X2 (1, N=440) = 0.202, p= .653]. Meanwhile, a positive significant relationship was found between respondents’ 
employment status and medication adherence [X2 (1, N=440) = 4.875, p= .027]. The results are presented in 
Table 3. 
 
Table 3. Chi-Square Statistics for “I feel better before I finish the medication” 
Demography Attribute X2 Value Df (Degree of freedom) Significance (2-sided) 
Age  0.858 4 0.931 
Marital Status  0.533 1 0.465 
Educational Level  0.529 1 0.216 
Employment status  4.875 1 0.027 
Sex  0.202 1 0.653 
Medication Payment  1.602 2 0.449 
 
4. Discussion 
The study investigated the reasons for non-adherence to malaria medication in outpatient setting. Age, marital 
status, educational level, gender, medication payment did not cause any variation in medication adherence 
behavior while employment status caused a significant variation i.e being employed makes me non-adherent. 
The factor “I feel better before I finish the medication” had the highest affirmative response and thus established 
as a prominent factor. This implies many of the respondents stop their anti-malaria medication before completing 
the prescribed dosage because they experience feelings of wellness after taking some of the medications. This 
factor has also been established from literature. Other reasons given include the fear of death, nauseating smell 
and taste of drugs, religious beliefs, the side effects of medication (dizziness, nausea, itching), quantity of drugs 
to take per time, the fear of taking fake (counterfeit) drugs or drugs that are past their expiry dates. Some 
respondents also prefer liquid drugs (syrup) to tablets, complained about the distance of health institutions, drug 
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stores (where original drugs are sold) and healthcare personnel to their homes. Others do not believe nor have 
confidence in the competence of the healthcare practitioners due to the contrary opinions of such personnel while 
some feel getting the required support and motivation from people who care and matter to them will make them 
adhere to their medications.  
4.1 Implications for Clinical Practice 
The findings from this work can be used in several ways in clinical practice. Employment status was found to 
have a negative influence on medication adherence rate. This may not make patients initiate or complete 
prescribed treatment regimen. Being employed (including being self-employed and the nature of job) connotes a 
busy lifestyle where medication may not fit in. For instance, individuals may find it difficult to take time off 
work to complete medical treatment such as injections and rehab therapy, fear of stigmatization or public 
knowledge of one’s health may prevent an individual from taking his medication at work, the side effects of 
some medication (e.g drowsiness) may also influence medication non-adherence. Health care providers should 
take into consideration the employment status and nature of job of patients before recommending, prescribing or 
initiating a treatment regimen. Prescriptions should fit into the patient’s work style.  
4.2 Implications for Employers  
Employers should create policies that encourage employees to take matters regarding their health status 
important. There should not be penalty for missing work based on health grounds. Employers should also take 
part or full responsibility for the financial implications of medical treatment. This will go a long way in 
motivating employees to visit health care providers and initiate prescribed treatment regimen.  
This study was conducted in southwest Nigeria; medication adherence interventions such as reminding, 
monitoring, informing and educating interventions could be designed to target these factors for outpatients living 
in this region. Instances include the use of electronic caps for drugs such that they record each time the patient 
opens the drug box, the use of mobile phones to send alerts to patients to remind them of their medication, 
mobile phones can also be used to inform and educate patients of the causes and preventive measures of ailments 
and diseases. Health care providers, personnel and institutions need to be aware of these factors. Efforts should 
be made to educate and inform patients on the need to complete their medication irrespective of how they feel. 
Incentives and rewards can be introduced into treatments. Patients who successfully complete their medication 
can be rewarded in the most suitable way.  
5. Conclusion 
This study is a cross-sectional study of factors influencing medication non-adherence among malaria outpatients 
in southwest Nigeria. These can give the requirements for the design of tailored and targeted interventions to 
control and influence adherence to medication. Such interventions could be evaluated to measure their 
effectiveness and efficiency. Adherence to medication will help to curb and reduce the prevalence of malaria, 
improve population health while reducing health risk factors. This will move Nigeria closer towards achieving 
the millennium development goal (MDG) on healthcare for all.  
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